D. Masciocchi

An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties

Federica Porta, Giorgio Facchetti, Nicola Ferri et al. · European Journal of Medicinal Chemistry · 2017 · 40 citations · Full text

Medicinal Chemistry, Medicine, Tumor Targeting +8

Biological and computational evaluation of an oxadiazole derivative (MD77) as a new lead for direct STAT3 inhibitors

D. Masciocchi, Stefania Villa, Fiorella Meneghetti et al. · MedChemComm · 2012 · 31 citations · Full text

Bioorganic Chemistry, Chemoprevention Strategy, Pharmacotherapy +23

Synthesis, modeling, and crystallographic study of 3,4-disubstituted-1,2,5-oxadiazoles and evaluation of their ability to decrease STAT3 activity

Dae‐Seop Shin, D. Masciocchi, Arianna Gelain et al. · MedChemComm · 2010 · 21 citations

Chemoprevention Strategy, Organic Chemistry, New Series +16

Synthesis, structure–activity relationships and stereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors

D. Masciocchi, Arianna Gelain, Federica Porta et al. · MedChemComm · 2013 · 19 citations · Full text

Pharmaceutical Science, Benzocinnolinone Derivative, Organic Chemistry +21

Ureido‐Pyridazinone Derivatives: Insights into the Structural and Conformational Properties for STAT3 Inhibition

Fiorella Meneghetti, Stefania Villa, D. Masciocchi et al. · European Journal of Organic Chemistry · 2015 · 10 citations

Molecular Pharmacology, Medicinal Chemistry, Diversity Oriented Synthesis +15